Back to mobile site
Get it on Google Play

BriaCell adds NYU cancer center to phase 3 breast cancer trial

May 7, 2026 7:30 AM EDT Send to a Friend
BriaCell Therapeutics Corp. (NASDAQ: BCTX) (TSX: BCT) announced the addition of NYU Langone Health's Perlmutter Cancer Center as a clinical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login